Human oocyte capacitation culture: Essential step toward hormone‐free assisted reproductive technology
Reproductive Medicine and Biology · 2025-01 · 24 (1)
DOI: 10.1002/rmb2.12640 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reproductive Medicine and Biology, online erschienen am 12.03.2025. Verfasst von Johan Smitz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Follicle Biology Laboratory, Faculty of Medicine and Pharmacy Vrije Universiteit Brussel Brussels Belgium. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Stichting Tegen Kanker, National Foundation for Science and Technology Development, Fonds Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Background
In vitro oocyte maturation (IVM) is not a novel concept; however, its wide‐scale practice has been limited because of the lower clinical outcomes compared to conventional assisted reproductive technologies.
Methods
This comprehensive review addresses the significant advances made in oocyte in vitro maturation with the biphasic capacitation (CAPA)‐IVM strategy applied to small ovarian antral follicles in humans over the last 10 years. CAPA‐IVM consists of a prematuration phase wherein immature oocytes are temporarily meiotically arrested to gain competence before undergoing meiotic resumption. Main findings The integration of knowledge from basic research in animal models into clinical practice has led to a reevaluation of IVM for policystic ovary syndrome (PCOS) and onco‐fertility patients. The introduction of meticulously conceived growth factors, hormonal supplements, and culture conditions led to an integrated biphasic CAPA‐IVM system that promotes oocyte competence. A series of prospective randomized controlled studies validated the reproducible improvements in clinical outcomes and the safety of CAPA‐IVM. So far, nearly 1000 babies have been born using this approach.
Conclusion
The use of CAPA‐IVM in clinical studies has set the tone for major progress in the field and is achieving a safer, less expensive, and less emotionally loaded IVF experience, currently validated for PCOS patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Follicle Biology Laboratory, Faculty of Medicine and Pharmacy Vrije Universiteit Brussel Brussels Belgium.
- Centro de Estudios e Investigaciones en Biología y Medicina Reproductiva Lima Peru.
- Centro de Fertilidad y Reproducción Asistida Lima Peru.
- Fertility & Research Centre, Discipline of Women's Health, School of Clinical Medicine University of New South Wales Sydney Sydney New South Wales Australia.
- IVFMD My Duc Hospital Ho Chi Minh City Viet Nam.
- HOPE Research Center Ho Chi Minh City Viet Nam.
ORCID-Profile: Flor Sánchez, Yoshiharu Morimoto
Förderung
- Stichting Tegen Kanker
- National Foundation for Science and Technology Development
- Fonds Wetenschappelijk Onderzoek
Zitieren
APA
Smitz, J., Sánchez, F., Romero, S., Van Ranst, H., Anckaert, E., Gilchrist, R. B., Ho, T. M., Vuong, L. N., & Morimoto, Y. (2025). Human oocyte capacitation culture: Essential step toward hormone‐free assisted reproductive technology. Reproductive Medicine and Biology, 24(1). https://doi.org/10.1002/rmb2.12640
Vancouver
Smitz J, Sánchez F, Romero S, Van Ranst H, Anckaert E, Gilchrist RB, et al. Human oocyte capacitation culture: Essential step toward hormone‐free assisted reproductive technology. Reproductive Medicine and Biology. 2025;24(1). doi:10.1002/rmb2.12640
BibTeX
@article{Smitz2025,
author = {Smitz, Johan and Sánchez, Flor and Romero, Sergio and Van Ranst, Heidi and Anckaert, Ellen and Gilchrist, Robert B and Ho, Tuong M and Vuong, Lan N and Morimoto, Yoshiharu},
title = {Human oocyte capacitation culture: Essential step toward hormone‐free assisted reproductive technology},
journal = {Reproductive Medicine and Biology},
year = {2025},
volume = {24},
number = {1},
doi = {10.1002/rmb2.12640}
}
EUVIMED